for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Malaysia buys additional 12.2 million doses of Pfizer-BioNTech COVID-19 vaccine

KUALA LUMPUR, Jan 11 (Reuters) - Malaysia on Monday signed a deal to buy an additional 12.2 million doses of a COVID-19 vaccine manufactured by U.S. and German drugmakers Pfizer and BioNTech, the health ministry said in a statement.

The deal brings the total amount of the Pfizer vaccines procured by Malaysia to 25 million doses, enough to cover 39% of its population, the ministry said. (Reporting by Rozanna Latiff; Editing by Martin Petty)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up